{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:20:46Z","timestamp":1791138046426,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1002\/jps.10030","type":"journal-article","created":{"date-parts":[[2004,10,25]],"date-time":"2004-10-25T19:03:58Z","timestamp":1098731038000},"page":"424-432","source":"Crossref","is-referenced-by-count":7,"title":["Single\u2010dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide"],"prefix":"10.1016","volume":"91","author":[{"given":"Arno","family":"Nolting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryanarayana","family":"Sista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wattanaporn","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.10030_bb0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/ajrccm\/141.3.584","article-title":"Peripheral resistance in normal and asthmatic subjects","volume":"141","author":"Wagner","year":"1990","journal-title":"Ann Rev Respir Dis"},{"key":"10.1002\/jps.10030_bb0015","first-page":"A629","article-title":"Elevated peripheral airway resistance (PAR) in nocturnal asthmatics (NA) is due to differing contributions from the airway and parenchyma","volume":"157","author":"Kraft","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/jps.10030_bb0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1164\/ajrccm.161.1.9804053","article-title":"Airway\u2010parenchyma uncoupling in nocturnal asthma","volume":"161","author":"Irvin","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/jps.10030_bb0025","unstructured":"The 1987 Montreal Protocol on Substances that Deplete the Ozone Layer: as adjusted and amended by the second Meeting of the Parties (London, 27\u201329 June 1990), and by the fourth Meeting of the Parties (Copenhagen, 23\u201325 November 1992), and further adjusted by the seventh Meeting of the Parties (Vienna, 5\u20137 December 1995), and further adjusted and amended by the ninth Meeting of the Parties (Montreal, 15\u201317 September 1997). Available athttp\/\/www.unep.org\/ozone\/mont_t.htm. Accessed January 16, 2001."},{"issue":"Suppl A","key":"10.1002\/jps.10030_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0954-6111(98)90211-6","article-title":"Improved delivery of inhaled steroids to the large and small airways","volume":"92","author":"Leach","year":"1998","journal-title":"Respir Med"},{"key":"10.1002\/jps.10030_bb0035","unstructured":"Data on file, Forest Laboratories."},{"key":"10.1002\/jps.10030_bb0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0954-6111(99)90000-8","article-title":"Inhaled corticosteroids for adult asthma: impact of formulation and delivery device on relative pharmacokinetics, efficacy and safety","volume":"93","author":"Shaw","year":"1999","journal-title":"Respir Med"},{"key":"10.1002\/jps.10030_bb0045","series-title":"Respiratory drug delivery","first-page":"405","article-title":"A scintigraphic study to assess the deposition of flunisolide delivered by HFA and CFC metered dose inhalers","author":"Richards","year":"1998"},{"key":"10.1002\/jps.10030_bb0050","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0091-6749(99)70016-3","article-title":"Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant","volume":"104","author":"Busse","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1002\/jps.10030_bb0055","article-title":"Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non\u2010CFC and CFC propellants","author":"Newman","year":"2001","journal-title":"J Aerosol Med"},{"key":"10.1002\/jps.10030_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/S1081-1206(10)62922-5","article-title":"Effective control of asthma with hydrofluoroalkane (HFA) flunisolide delivered as an extrafine aerosol in asthma patients","author":"Corren","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1002\/jps.10030_bb0065","series-title":"Expert panel report 2: guidelines for the diagnosis and management of asthma","first-page":"97","year":"1997"},{"key":"10.1002\/jps.10030_bb0070","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/thx.39.12.935","article-title":"Improvement of pressurised aerosol deposition with Nebuhaler spacer device","volume":"39","author":"Newman","year":"1984","journal-title":"Thorax"},{"key":"10.1002\/jps.10030_bb0075","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1164\/arrd.1984.129.5.723","article-title":"Use of spacers to facilitate inhaled corticosteroid treatment of asthma","volume":"129","author":"Toogood","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1002\/jps.10030_bb0080","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1378\/chest.116.4.935","article-title":"Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered\u2010dose inhaler","volume":"116","author":"Dempsey","year":"1999","journal-title":"Chest"},{"key":"10.1002\/jps.10030_bb0085","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/thx.45.10.736","article-title":"Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids?","volume":"45","author":"Brown","year":"1990","journal-title":"Thorax"},{"key":"10.1002\/jps.10030_bb0090","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/thx.45.10.740","article-title":"Morning serum cortisol concentrations after 2 mg inhaled beclomethasone dipropionate in normal subjects: effect of a 750 ml spacing device","volume":"45","author":"Farrer","year":"1990","journal-title":"Thorax"},{"key":"10.1002\/jps.10030_bb0095","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1365-2125.1996.00493.x","article-title":"Pharmacokinetics of inhaled drugs","volume":"42","author":"Lipworth","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/jps.10030_bb0100","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1081-1206(10)62517-3","article-title":"Pharmacokinetics of flunisolide administered via metered dose inhaler with and without a spacer device and following oral administration","volume":"84","author":"Dickens","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1002\/jps.10030_bb0105","first-page":"16","article-title":"Mechanism for the oxidative defluorination of flunisolide","volume":"218","author":"Teitelbaum","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.10030_bb0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1980.54","article-title":"Flunisolide metabolism and dynamics of a metabolite","volume":"27","author":"Chaplin","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/jps.10030_bb0115","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta\u2010analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1002\/jps.10030_bb0120","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/j.1552-4604.1997.tb04263.x","article-title":"Pharmacokinetic\/pharmacodynamic evaluation of systemic effects of flunisolide after inhalation","volume":"37","author":"M\u00f6llmann","year":"1997","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1002\/jps.10030_bb0125","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1089\/jam.1996.9.Suppl_1.S-77","article-title":"In vivo measurements of aerosol dose and distribution: clinical relevance","volume":"9","author":"Laube","year":"1996","journal-title":"J Aerosol Med"},{"key":"10.1002\/jps.10030_bb0130","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1016\/S0091-6749(99)70043-6","article-title":"Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin\u2010section computed tomography","volume":"104","author":"Goldin","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1002\/jps.10030_bb0135","series-title":"Asthma and the small airways","first-page":"7","article-title":"Evaluation of small airways and the impact of inhaled steroids\u2014size does matter","author":"Tashkin","year":"2000"},{"issue":"Suppl 4","key":"10.1002\/jps.10030_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003495-199958004-00002","article-title":"Pharmacological factors that influence the choice of inhaled corticosteroids","volume":"58","author":"Edsb\u00e4cker","year":"1999","journal-title":"Drugs"},{"key":"10.1002\/jps.10030_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2500\/108854191778879601","article-title":"Aerosol physiology, deposition, and metered dose inhalers","volume":"12","author":"Newman","year":"1991","journal-title":"Allergy Proc"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916309212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916309212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T16:25:40Z","timestamp":1549124740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916309212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0022354916309212"],"URL":"https:\/\/doi.org\/10.1002\/jps.10030","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}